Received Mar 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | BP74J | IM / LA |
Patient presented to the pharmacy in the evening on 2/24 reporting that she experienced redness below the injection site the day after administration (2/19) that progressed to swelling and heat the following day (2/20). She reports these adverse effects improved through the weekend, but she developed a painful, red, itchy, swollen, warm to the touch, almost bruised area the following Monday (2/24) even farther down the arm from the injection site (a bit above the elbow). She wanted to know if what she was experiencing was typical following Shingrix administration. Pharmacy advised patient to reach out to her doctor for assessment and for advisement on second dose administration given the length of time involved in the incident and the fact that the patient's symptoms improved and then quickly worsened days later. Pharmacy advised patient that symptoms could potentially be attributed to a delayed sensitivity/mild allergic reaction to the vaccine and that if symptoms worsened (spreading rash, hives, swelling of the face, difficulty breathing, etc.) she should seek immediate medical attention. Pharmacy followed up with patient by phone on 2/26. Patient reported that she had some mild, lingering itchiness in the area, but that the rash and bruising were gone. Patient further reported that while she had contacted her doctor, they never got back to her and she sought no other medical attention for the issue. Pharmacy advised patient to still follow up with her doctor on second dose advisement.